Viral Safety and Viral Clearance Summit Resources
Watch our 2025 Summit recap video from Cologne, Germany, to learn key industry insights.
Sign up now to be the first to get updates about next year's event. Pre-register here: [email protected].
Gain insight from industry experts, academic researchers, and expert regulatory authorities as they explore new technologies, best practices, and how to design an efficient manufacturing process.
Access panel discussions, presentation recordings, and interviews with key opinion leaders. Examples of available content:
Usefulness/Applicability of Virus Co-spiking in Virus Clearance Study | Yukichi Hatano, MSc, Bioprocess Unit Manager (Associate Director), JCR Pharmaceuticals
Panel Discussion: Viral Clearance & Viral Safety Q&A with Industry & Regulatory Experts | Moderated by: Horst Ruppach, PhD, Executive Director Scientific and Portfolio, Global Biologics, Charles River
Review of Current NGS Related Regulations and it’s Meaning for NGS Acceptance | Horst Ruppach, PhD, Executive Director Scientific and Portfolio, Global Biologics, Charles River
The FDA's Reference Viral Database | Pei-Ju Chin, MS, PhD, Staff Fellow, US Food and Drug Administration
Next-Generation Minute Mouse Virus (MMV) Stock Impact on Small-Scale Viral Filter Performance | Alyssa Lovullo, Scientist, Biosafety Development (BSD), Amgen
Adapting Virus Filtration Operation to Continuous Processing Challenges | Christine Stouffer, Senior Research Associate, Asahi Kasei Bioprocess
Understanding the Challenges and Guidelines of Cell and Gene Therapy within Viral Clearance | Tareq Jaber, Associate Director, Process Evaluation, Charles River
New Insights into Low pH Viral Inactivation | Etienne Utiger, Scientist, AstraZeneca